Hubro Therapeutics AS (private company)
See something wrong or missing? Let us know
Offices:Oslo
Industry:Health services
Business model:B2B
Hubro Therapeutics develops a technology platform for cancer vaccines targeting stomach and colon cancer - Hubro Therapeutics develops immunotherapies for treatment of cancer. The product candidates are novel neoantigen targeted cancer vaccines for activation of anti-cancer specific T cell immune responses.
Hubro Therapeutics went bankrupt in 2024.
Investors:
we tracked 2 investors
You need an account to access this feature. Log in or create one from here.
Do you have a question? Talk to us.
values in USD
Investments 828.169k
You need an account to access this feature. Log in or create one from here.
Do you have a question? Talk to us.
Companies with similar profile to Hubro Therapeutics AS
Name | Criteria | |
---|---|---|
![]() |
3Z Pharmaceuticals
36%
|
|
![]() |
Adesante
36%
|
|
![]() |
ADmit Therapeutics
36%
|
|
![]() |
Anatomic Studios
36%
|
|
![]() |
BiBB Instruments
36%
|
|
![]() |
Boost Thyroid
36%
|
|
![]() |
Challengize
36%
|
|
![]() |
Cope IT
36%
|
|
![]() |
Creat Sens
36%
|
|
![]() |
Dentaltix
36%
|
|